About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Cleveland | 263 Studies

Clinical Trials Prostate CancerCleveland

Prostate Cancer Clinical Trials in Cleveland

Find 263 clinical trials for prostate cancer near Cleveland, Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Cleveland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 263 trials

Not yet recruitingPhase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate CancerThis research study is for people with metastatic castrate-resistant prostate cancer (mCRPC).NCT07608718·Cleveland, Ohio Active not recruitingProton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerWe are studying whether men being treated for prostate cancer have the same amount of side effects from either one of two different external radiation treatments: IMRT or PBT.NCT01617161·Jacksonville, Florida and 12 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRadiation Therapy in Treating Patients With Stage II Prostate CancerRATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving hypofractionated…NCT00331773·Phoenix, Arizona and 295 others

CompletedStudy of Individualized Amonafide to Treat Prostate CancerThe purpose of this study is to assess the safety and efficacy of Amonafide in men with androgen-independent prostate cancer, assigned to individualized doses of Amonafide based…NCT00087854·Los Angeles, California and 7 others

TerminatedStudy Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined CancersThis is a Phase II, open-label, 2-arm, multicenter, international study designed to evaluate the efficacy of zenocutuzumab alone or in combination in patients with the following…NCT05588609·Whittier, California and 6 others

CompletedHormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00005044·Birmingham, Alabama and 260 others

Active not recruitingSpaceIT Hydrogel System for Perirectal SpacingTo evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.NCT06451614·Laguna Hills, California and 25 others

CompletedHigh-Dose Stereotactic Radiation for Prostate CancerThis clinical trial studies high-dose stereotactic body radiation therapy (SBRT) in treating patients with low-, intermediate-, or high-risk localized prostate cancer.NCT01664130·Cleveland, Ohio

CompletedHormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT01546987·Birmingham, Alabama and 171 others

CompletedNAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer PatientsAfrican-Americans have disparately limited access to optimal cancer care.NCT05978232·Cleveland, Ohio

CompletedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer.NCT00002602·Birmingham, Alabama and 227 others

Active not recruitingNational Cancer Institute "Cancer Moonshot Biobank"This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study.NCT04314401·Daphne, Alabama and 149 others

TerminatedTreatment Decision Analysis Model for Prostate Cancer: A Randomized TrialThis is a psychosocial/behavioral study and does not involve administration of any treatment or diagnostic procedures.NCT02024685·Cleveland, Ohio

CompletedExternal-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells.NCT00006365·Birmingham, Alabama and 253 others

RecruitingEvaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancErThis study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk…NCT05948657·Los Angeles, California and 3 others

CompletedExercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate CancerThis study is being done to determine if patients receiving personalized exercise therapy (versus those who do not receive personalized exercise therapy) have improved quality of…NCT04556045·Cleveland, Ohio

CompletedA Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical ProstatectomyThe purpose of the study is to compare the safety and effectiveness of Prograf in the prevention of erectile dysfunction in men after a radical prostatectomy.NCT00106392·Ann Arbor, Michigan and 5 others

UnknownA Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)For the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT)NCT00772317·Los Angeles, California and 15 others

CompletedEMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate CancerThe primary objective of the trial is to evaluate the clinical anti-tumor activity of EMD 525797 administered as 1-hour intravenous infusion every 3 weeks in terms of progression…NCT01360840·Pleasant Hill, California and 70 others

CompletedIpatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of ipatasertib plus abiraterone and prednisone/prednisolone compared with placebo plus…NCT03072238·Chandler, Arizona and 175 others

PreviousPage 10 of 14Next

Other Conditions in Cleveland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma